Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands

被引:58
|
作者
Crawford, F
Jordan, KR
Stadinski, B
Wang, YB
Huseby, E
Marrack, P
Slansky, JE
Kappler, JW
机构
[1] Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Integrated Dept Immunol, Denver, CO 80206 USA
[2] Natl Jewish Med & Res Ctr, Howard Hughes Med Inst, Denver, CO USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80202 USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA
[5] Univ Colorado, Hlth Sci Ctr, Program Biomol Struct, Denver, CO 80262 USA
关键词
D O I
10.1111/j.0105-2896.2006.00365.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peptide/protein display libraries are powerful tools for identifying and manipulating receptor/ligand pairs. While the large size of bacterial phage display libraries has made them the platform of choice in many applications, often considerable engineering has been required to achieve display of properly folded and active eukaryotic proteins, such as antibodies. This problem has been partially solved in several eukaryotic display systems, e.g. using yeast or retroviruses, but these systems have their own limitations. Recently, baculovirus has been developed as a display system using the virus itself or infected insect cells as the display platform. Here, we review the development and use of baculovirus-infected cells as a platform for display libraries of peptides bound to major histocompatibility complex (MHC) class I (MHCI) or class II (MHCII). We have used fluorescent multimeric soluble T-cell receptors (TCRs) to screen these libraries and to identify peptide antigen mimotopes. We also present some improvements to this system that allow very large libraries to be constructed and screened. We have used these libraries to examine the role of MHCII-bound peptides in the presentation of the staphylococcal enterotoxin A (SEA) and to manipulate an MHCI tumor-associated antigen.
引用
收藏
页码:156 / 170
页数:15
相关论文
共 50 条
  • [41] Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices
    Singha S.
    Shao K.
    Yang Y.
    Clemente-Casares X.
    Solé P.
    Clemente A.
    Blanco J.
    Dai Q.
    Song F.
    Liu S.W.
    Yamanouchi J.
    Umeshappa C.S.
    Nanjundappa R.H.
    Detampel P.
    Amrein M.
    Fandos C.
    Tanguay R.
    Newbigging S.
    Serra P.
    Khadra A.
    Chan W.C.W.
    Santamaria P.
    Nature Nanotechnology, 2017, 12 (7) : 701 - 710
  • [42] A new paradigm for targeting gene delivery: Exploiting T-cell receptor and MHC/peptide interactions
    Peng, KW
    Holler, PD
    Orr, B
    Kranz, DM
    Russell, SJ
    MOLECULAR THERAPY, 2003, 7 (05) : S25 - S25
  • [43] T-cell receptor peptide-MHC interactions: biological lessons from structural studies
    Garcia, KC
    Teyton, L
    CURRENT OPINION IN BIOTECHNOLOGY, 1998, 9 (04) : 338 - 343
  • [44] Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices
    Singha, Santiswarup
    Shao, Kun
    Yang, Yang
    Clemente-Casares, Xavier
    Sole, Patricia
    Clemente, Antonio
    Blanco, Jesus
    Dai, Qin
    Song, Fayi
    Liu, Shang Wan
    Yamanouchi, Jun
    Umeshappa, Channakeshava Sokke
    Nanjundappa, Roopa Hebbandi
    Detampel, Pascal
    Amrein, Matthias
    Fandos, Cesar
    Tanguay, Robert
    Newbigging, Susan
    Serra, Pau
    Khadra, Anmar
    Chan, Warren C. W.
    Santamaria, Pere
    NATURE NANOTECHNOLOGY, 2017, 12 (07) : 701 - +
  • [45] T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand
    Kaushik Choudhuri
    David Wiseman
    Marion H. Brown
    Keith Gould
    P. Anton van der Merwe
    Nature, 2005, 436 : 578 - 582
  • [46] Engineered T-cell receptor tetramers bind MHC-peptide complexes with high affinity
    Subbramanian, RA
    Moriya, C
    Martin, KL
    Peyerl, FW
    Hasegawa, A
    Naoi, A
    Chhay, H
    Autissier, P
    Gorgone, DA
    Lifton, MA
    Kuus-Reichel, K
    Schmitz, JE
    Letvin, NL
    Kuroda, MJ
    NATURE BIOTECHNOLOGY, 2004, 22 (11) : 1429 - 1434
  • [47] Initiation of signal transduction through the T cell receptor requires the peptide multivalent engagement of MHC ligands
    Boniface, JJ
    Rabinowitz, JD
    Wülfing, C
    Hampl, J
    Reich, Z
    Altman, JD
    Kantor, RM
    Beeson, C
    McConnell, HM
    Davis, MM
    IMMUNITY, 1998, 9 (04) : 459 - 466
  • [48] THE INTERACTION OF A T-CELL RECEPTOR WITH VARIOUS LIGANDS
    JANEWAY, CA
    HONG, SC
    YOON, SW
    SANTANGELO, D
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 285 - 285
  • [49] ALLOREACTIVE T-CELL RECOGNITION OF MHC-PEPTIDE COMPLEXES
    BRAUNSTEIN, NS
    HARRIS, M
    RASCOFF, H
    ZHANG, Y
    HEXNER, E
    GRUBIN, C
    RUDENSKY, A
    EGUIA, J
    BHAGAT, G
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 88 - 88
  • [50] ALLOREACTIVE T-CELL RECOGNITION OF MHC-PEPTIDE COMPLEXES
    BRAUNSTEIN, NS
    WEBER, DA
    TERRELL, NK
    ZHANG, Y
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 381 - 381